Genomewide association analysis of coronary artery disease

New England Journal of Medicine

Volumn 357, Issue 5, 2007, Pages 443-453

  Samani, Nilesh J ^a,l   Erdmann, Jeanette ^e   Hall, Alistair S ^b   Hengstenberg, Christian ^f   Mangino, Massimo ^a   Mayer, Bjoern ^e   Dixon, Richard J ^a   Meitinger, Thomas ^g,h   Braund, Peter ^a   Wichmann, H Erich ^g,i   Barrett, Jennifer H ^b   König, Inke R ^e   Stevens, Suzanne E ^a   Szymczak, Silke ^e   Tregouet, David Alexandre ^k   Iles, Mark M ^b   Pahlke, Friedrich ^e   Pollard, Helen ^a   Lieb, Wolfgang ^e   Cambien, Francois ^k   Fischer, Marcus ^f   Ouwehand, Willem ^c   Blankenberg, Stefan ^j   Balmforth, Anthony J ^b   Baessler, Andrea ^f   Ball, Stephen G ^b   Strom, Tim M ^g   Brænne, Ingrid ^e   Gieger, Christian ^g,i   Deloukas, Panos ^d   Tobin, Martin D ^a   Ziegler, Andreas ^e   Thompson, John R ^a   Schunkert, Heribert ^e   more..

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e UNIVERSITY OF LÜBECK   (Germany)

^f UNIVERSITY OF REGENSBURG   (Germany)

^g INSTITUTE OF EPIDEMIOLOGY   (Germany)

^h TECHNICAL UNIVERSITY OF MUNICH   (Germany)

ⁱ UNIVERSITY OF MUNICH   (Germany)

^j JOHANNES GUTENBERG UNIVERSITY   (Germany)

^k INSERM   (France)

^l UNIVERSITY OF LEICESTER   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHROMOSOME 10Q; CHROMOSOME 15Q; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME 2Q; CHROMOSOME 6Q; CHROMOSOME 9P; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DNA MICROARRAY; FALSE POSITIVE RESULT; FAMILY STUDY; FEMALE; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC RISK; GENOME ANALYSIS; GENOTYPE; GERMANY; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROBABILITY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 34547623750     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa072366     Document Type: Article

References (32)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-57.
2. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
3. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994;330:1041-6.
4. Christensen K, Murray JC. What genome-wide association studies can do for medicine. N Engl J Med 2007;356:1094-7.
5. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-78.
6. Samani NJ, Burton P, Mangino M, et al. A genomewide linkage study of 1,933 families affected by premature coronary artery disease: The British Heart Foundation (BHF) Family Heart Study. Am J Hum Genet 2005;77:1011-20.
7. Alfakih K, Brown B, Lawrance RA, et al. Effect of a common X-linked angiotensin II type 2-receptor gene polymorphism (-1332 G/A) on the occurrence of premature myocardial infarction and stenotic atherosclerosis requiring revascularization. Atherosclerosis (in press).
8. Broeckel U, Hengstenberg C, Mayer B, et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet 2002;30:210-4.
9. Fischer M, Broeckel U, Holmer S, et al. Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction. Circulation 2005;111:855-62.
10. Wichmann HE, Gieger C, Illig T. KORA-gen - resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 2005;67:Suppl 1:S26-S30.
11. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004;96:434-42.
12. International HapMap Consortium. A haplotype map of the human genome. Nature 2005;437:1299-320.
13. McPherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007;316:1488-91.
14. Helgadottir A, Thorleifsson G, Manolescu A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007;316:1491-3.
15. Lowe SW, Sherr CJ. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr Opin Genet Dev 2003;13:77-83.
16. Hannon GJ, Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 1994;371:257-61.
17. Kalinina N, Agrotis A, Antropova Y, et al. Smad expression in human atherosclerotic lesions: evidence for impaired TGFbeta/Smad signaling in smooth muscle cells of fibrofatty lesions. Arterioscler Thromb Vasc Biol 2004;24:1391-6.
18. Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007;316:1341-5.
19. Zeggini E, Weedon MN, Lindgren CM, et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007;316:1336-41.
20. Saxena R, Voight BF, Lyssenko V, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007;316:1331-6.
21. Prasannan P, Pike S, Peng K, Shane B, Appling DR. Human mitochondrial C1-tetrahydrofolate synthase: gene structure, tissue distribution of the mRNA, and immunolocalization in Chinese hamster ovary calls. J Biol Chem 2003;278:43178-87.
22. Walkup AS, Appling DR. Enzymatic characterization of human mitochondrial C1-tetrahydrofolate synthase. Arch Biochem Biophys 2005;442:196-205.
23. Randak C, Roschinger W, Rolinski B, Hadorn HB, Applegarth DA, Roscher AA. Three siblings with nonketotic hyperglycinaemia, mildly elevated plasma homocysteine concentrations and moderate methylmalonic aciduria. J Inherit Metab Dis 2000;23:520-2.
24. Fruchart JC, Nierman MC, Stroes ES, Kastelein JJ, Duriez P. New risk factors for atherosclerosis and patient risk assessment. Circulation 2004;109:Suppl I:III-15-III-9.
25. Tiret L, Godefroy T, Lubos E, et al. Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation 2005;112:643-50.
26. Lo PK, Chen JY, Lo WC, et al. Identification of a novel mouse p53 target gene DDA3. Oncogene 1999;18:7765-74.
27. Bosserhoff AK, Buettner R. Expression, function and clinical relevance of MIA (melanoma inhibitory activity). Histol Histopathol 2002;17:289-300.
28. Qin BY, Lam SS, Correia JJ, Lin K. Smad3 allostery links TGF-beta receptor kinase activation to transcriptional control. Genes Dev 2002;16:1950-63.
29. Miyazono K. TGF-beta signaling by Smad proteins. Cytokine Growth Factor Rev 2000;11:15-22.
30. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation 2005;111:3481-8.
31. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996;273:1516-7.
32. Morgan TM, Krumholz HM, Lifton RP, Spertus JA. Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA 2007;297:1551-61.